In the preparation of the aforementioned article, two panels within Figure 4A were erroneously inserted twice, thus leading to incorrect labeling and duplications; this affected the images corresponding to 3T3L1 control (top left); 3T3L1-GRK2+insulin (middle left); L1+insulin+SB, an established p38 MAPK inhibitor (bottom left); and K220R+insulin+SB (bottom right). The corrected Figure 4A , presented below, now shows the appropriate panels and labels, in which the top left (undifferentiated 3T3L1 cell control) and the middle left (showing decreased differentiation by insulin in the presence of extra GRK2) panels within Figure 4A have been substituted for the correct ones. This change does not affect the conclusions of the paper in any way. The authors sincerely apologize to the readers for any confusion that may have resulted from this error.
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